Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial quorum sensing (QS) signaling pathways are sophisticated communication systems used by bacteria to coordinate collective behaviors based on population density. This process relies on the production and detection of extracellular signaling molecules called autoinducers, such as acyl-homoserine lactones (AHLs) in Gram-negative bacteria and oligopeptides in Gram-positive bacteria (Miller & Bassler, 2001, Annual Review of Microbiology). When these molecules reach a critical threshold concentration, they bind to cognate receptors, typically transcription factors, triggering the synchronized expression of genes involved in virulence, biofilm formation, and antibiotic resistance (Rutherford & Bassler, 2012, Cold Spring Harbor Perspectives in Medicine). In human disease, QS is central to the pathogenesis of chronic infections, particularly those involving Pseudomonas aeruginosa in cystic fibrosis and Staphylococcus aureus in skin infections (Whiteley et al., 2017, Nature). Therapeutic strategies targeting these pathways, often termed quorum quenching, aim to attenuate bacterial virulence without exerting the strong selective pressure for resistance associated with traditional bactericidal antibiotics (Grandclément et al., 2016, FEMS Microbiology Reviews). Drugs like azithromycin have been shown to possess secondary QS-inhibitory effects, and various synthetic inhibitors and enzymes are currently under investigation to disrupt these signaling networks (Imperi et al., 2014, Antimicrobial Agents and Chemotherapy).
Inhibition of autoinducer synthesis, enzymatic degradation of signaling molecules (quorum quenching), or competitive antagonism of signal receptors to prevent the activation of downstream virulence genes.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial quorum sensing signaling pathways (QS).